Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Pharmacokinetics of a New Pharmaceutical Form of Vitamin D3 100,000 IU in Soft Capsule.

Mentaverri R, Souberbielle JC, Brami G, Daniel C, Fardellone P.

Nutrients. 2019 Mar 26;11(3). pii: E703. doi: 10.3390/nu11030703.

2.

Activation of the calcium-sensing receptor in human valvular interstitial cells promotes calcification.

Issa H, Hénaut L, Abdallah JB, Boudot C, Lenglet G, Avondo C, Ibrik A, Caus T, Brazier M, Mentaverri R, Zibara K, Kamel S.

J Mol Cell Cardiol. 2019 Apr;129:2-12. doi: 10.1016/j.yjmcc.2019.01.021. Epub 2019 Feb 12.

3.

Differential Determinants of Tubular Phosphate Reabsorption: Insights on Renal Excretion of Phosphates in Kidney Disease.

Tabibzadeh N, Mentaverri R, Daroux M, Mesbah R, Delpierre A, Paul JG, Deken V, Massy ZA, Bataille P.

Am J Nephrol. 2018;47(5):300-303. doi: 10.1159/000488864. Epub 2018 May 18.

PMID:
29779025
4.

Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD.

Liabeuf S, Ryckelynck JP, El Esper N, Ureña P, Combe C, Dussol B, Fouque D, Vanhille P, Frimat L, Thervet E, Mentaverri R, Prié D, Choukroun G; FRENCH Study collaborators.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1930-1940. doi: 10.2215/CJN.03030317. Epub 2017 Oct 26.

5.

Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study.

Lenglet A, Liabeuf S, Esper NE, Brisset S, Mansour J, Lemaire-Hurtel AS, Mary A, Brazier M, Kamel S, Mentaverri R, Choukroun G, Fournier A, Massy ZA.

Nephrol Dial Transplant. 2017 Sep 1;32(9):1597. doi: 10.1093/ndt/gfx249. No abstract available.

PMID:
29059402
6.

Overexpression of a functional calcium-sensing receptor dramatically increases osteolytic potential of MDA-MB-231 cells in a mouse model of bone metastasis through epiregulin-mediated osteoprotegerin downregulation.

Boudot C, Hénaut L, Thiem U, Geraci S, Galante M, Saldanha P, Saidak Z, Six I, Clézardin P, Kamel S, Mentaverri R.

Oncotarget. 2017 Apr 10;8(34):56460-56472. doi: 10.18632/oncotarget.16999. eCollection 2017 Aug 22.

7.

Higher parathyroid hormone levels are associated with increased below-the-knee arterial calcification in type 2 diabetes.

Mary A, Hartemann A, Brazier M, Aubert CE, Kemel S, Salem JE, Cluzel P, Liabeuf S, Massy Z, Mentaverri R, Bourron O, Kamel S.

Diabetes Metab. 2018 Jun;44(3):305-308. doi: 10.1016/j.diabet.2017.04.008. Epub 2017 Jun 8. No abstract available.

PMID:
28602488
8.

Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients.

Mary A, Hartemann A, Liabeuf S, Aubert CE, Kemel S, Salem JE, Cluzel P, Lenglet A, Massy ZA, Lalau JD, Mentaverri R, Bourron O, Kamel S.

Cardiovasc Diabetol. 2017 Feb 15;16(1):24. doi: 10.1186/s12933-017-0509-7.

9.

Expression of the calcium-sensing receptor in monocytes from synovial fluid is increased in osteoarthritis.

Séjourné A, Boudot C, Objois T, Fardellone P, Brazier M, Six I, Kamel S, Mentaverri R, Goëb V.

Joint Bone Spine. 2017 Mar;84(2):175-181. doi: 10.1016/j.jbspin.2016.03.012. Epub 2016 Jun 23.

PMID:
27346252
10.

Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study.

Lenglet A, Liabeuf S, El Esper N, Brisset S, Mansour J, Lemaire-Hurtel AS, Mary A, Brazier M, Kamel S, Mentaverri R, Choukroun G, Fournier A, Massy ZA.

Nephrol Dial Transplant. 2017 May 1;32(5):870-879. doi: 10.1093/ndt/gfw042.

PMID:
27190329
11.

[Pathophysiological mechanisms of vascular calcification].

Hénaut L, Mentaverri R, Liabeuf S, Bargnoux AS, Delanaye P, Cavalier É, Cristol JP, Massy Z, Kamel S; Groupe de Travail Biomarqueurs des Calcifications Vasculaires de la SFBC et de la Société de Néphrologie.

Ann Biol Clin (Paris). 2015 May-Jun;73(3):271-87. doi: 10.1684/abc.2015.1044. Review. French.

12.

Calcitriol prevents in vitro vascular smooth muscle cell mineralization by regulating calcium-sensing receptor expression.

Mary A, Hénaut L, Boudot C, Six I, Brazier M, Massy ZA, Drüeke TB, Kamel S, Mentaverri R.

Endocrinology. 2015 Jun;156(6):1965-74. doi: 10.1210/en.2014-1744. Epub 2015 Mar 12.

PMID:
25763635
13.

The calcium-sensing receptor: A promising target for prevention of colorectal cancer.

Aggarwal A, Prinz-Wohlgenannt M, Tennakoon S, Höbaus J, Boudot C, Mentaverri R, Brown EM, Baumgartner-Parzer S, Kállay E.

Biochim Biophys Acta. 2015 Sep;1853(9):2158-67. doi: 10.1016/j.bbamcr.2015.02.011. Epub 2015 Feb 18.

14.

Erratum: Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein.

Liabeuf S, Bourron O, Vemeer C, Theuwissen E, Magdeleyns E, Aubert CE, Brazier M, Mentaverri R, Hartemann A, Massy ZA.

Cardiovasc Diabetol. 2015 Jan 24;14:9. doi: 10.1186/s12933-014-0164-1. No abstract available.

15.

Low-gradient, low-flow severe aortic stenosis with preserved left ventricular ejection fraction: characteristics, outcome, and implications for surgery.

Tribouilloy C, Rusinaru D, Maréchaux S, Castel AL, Debry N, Maizel J, Mentaverri R, Kamel S, Slama M, Lévy F.

J Am Coll Cardiol. 2015 Jan 6;65(1):55-66. doi: 10.1016/j.jacc.2014.09.080. Erratum in: J Am Coll Cardiol. 2015 Mar 24;65(11):1159-60.

16.

Coronary and abdominal aorta calcification in rheumatoid arthritis: relationships with traditional cardiovascular risk factors, disease characteristics, and concomitant treatments.

Paccou J, Renard C, Liabeuf S, Kamel S, Fardellone P, Massy ZA, Brazier M, Mentaverri R.

J Rheumatol. 2014 Nov;41(11):2137-44. doi: 10.3899/jrheum.140239. Epub 2014 Oct 1.

PMID:
25274891
17.

The Association between 25-Hydroxyvitamin D and Hemoglobin A1c Levels in Patients with Type 2 Diabetes and Stage 1-5 Chronic Kidney Disease.

Kajbaf F, Mentaverri R, Diouf M, Fournier A, Kamel S, Lalau JD.

Int J Endocrinol. 2014;2014:142468. doi: 10.1155/2014/142468. Epub 2014 Aug 27.

18.

The relationships between serum sclerostin, bone mineral density, and vascular calcification in rheumatoid arthritis.

Paccou J, Mentaverri R, Renard C, Liabeuf S, Fardellone P, Massy ZA, Brazier M, Kamel S.

J Clin Endocrinol Metab. 2014 Dec;99(12):4740-8. doi: 10.1210/jc.2014-2327.

PMID:
25222755
19.

Total calcium-sensing receptor expression in circulating monocytes is increased in rheumatoid arthritis patients with severe coronary artery calcification.

Paccou J, Boudot C, Renard C, Liabeuf S, Kamel S, Fardellone P, Massy Z, Brazier M, Mentaverri R.

Arthritis Res Ther. 2014 Aug 19;16(5):412. doi: 10.1186/s13075-014-0412-5.

20.

Below-knee arterial calcification in type 2 diabetes: association with receptor activator of nuclear factor κB ligand, osteoprotegerin, and neuropathy.

Bourron O, Aubert CE, Liabeuf S, Cluzel P, Lajat-Kiss F, Dadon M, Komajda M, Mentaverri R, Brazier M, Pierucci A, Morel F, Jacqueminet S, Massy ZA, Hartemann A.

J Clin Endocrinol Metab. 2014 Nov;99(11):4250-8. doi: 10.1210/jc.2014-1047. Epub 2014 Jul 11.

PMID:
25013993
21.

Osteoclasts and their precursors are present in the induced-membrane during bone reconstruction using the Masquelet technique.

Gouron R, Petit L, Boudot C, Six I, Brazier M, Kamel S, Mentaverri R.

J Tissue Eng Regen Med. 2017 Feb;11(2):382-389. doi: 10.1002/term.1921. Epub 2014 Jun 12.

PMID:
24919776
22.

Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein.

Liabeuf S, Bourron O, Olivier B, Vemeer C, Theuwissen E, Magdeleyns E, Aubert CE, Brazier M, Mentaverri R, Hartemann A, Massy ZA.

Cardiovasc Diabetol. 2014 Apr 24;13:85. doi: 10.1186/1475-2840-13-85. Erratum in: Cardiovasc Diabetol. 2015 Jan 24;14:9. Olivier, Bourron [corrected to Bourron, Olivier].

23.

Calcimimetics increase CaSR expression and reduce mineralization in vascular smooth muscle cells: mechanisms of action.

Hénaut L, Boudot C, Massy ZA, Lopez-Fernandez I, Dupont S, Mary A, Drüeke TB, Kamel S, Brazier M, Mentaverri R.

Cardiovasc Res. 2014 Feb 1;101(2):256-65. doi: 10.1093/cvr/cvt249. Epub 2013 Nov 11.

PMID:
24217682
24.

Determination and modulation of total and surface calcium-sensing receptor expression in monocytes in vivo and in vitro.

Paccou J, Boudot C, Mary A, Kamel S, Drüeke TB, Fardellone P, Massy Z, Brazier M, Mentaverri R.

PLoS One. 2013 Oct 1;8(10):e74800. doi: 10.1371/journal.pone.0074800. eCollection 2013.

25.

Calcium sensing receptor signalling in physiology and cancer.

Brennan SC, Thiem U, Roth S, Aggarwal A, Fetahu ISh, Tennakoon S, Gomes AR, Brandi ML, Bruggeman F, Mentaverri R, Riccardi D, Kallay E.

Biochim Biophys Acta. 2013 Jul;1833(7):1732-44. doi: 10.1016/j.bbamcr.2012.12.011. Epub 2012 Dec 23. Review.

26.

Bone complications of mastocytosis: a link between clinical and biological characteristics.

Guillaume N, Desoutter J, Chandesris O, Merlusca L, Henry I, Georgin-Lavialle S, Barete S, Hirsch I, Bouredji D, Royer B, Gruson B, Lok C, Sevestre H, Mentaverri R, Brazier M, Meynier J, Hermine O, Marolleau JP, Kamel S, Damaj G.

Am J Med. 2013 Jan;126(1):75.e1-7. doi: 10.1016/j.amjmed.2012.07.018. Epub 2012 Nov 28.

PMID:
23200108
27.

Vascular calcification in rheumatoid arthritis: prevalence, pathophysiological aspects and potential targets.

Paccou J, Brazier M, Mentaverri R, Kamel S, Fardellone P, Massy ZA.

Atherosclerosis. 2012 Oct;224(2):283-90. doi: 10.1016/j.atherosclerosis.2012.04.008. Epub 2012 May 8. Review.

PMID:
22703866
28.

The onset of left ventricular diastolic dysfunction in SHR rats is not related to hypertrophy or hypertension.

Dupont S, Maizel J, Mentaverri R, Chillon JM, Six I, Giummelly P, Brazier M, Choukroun G, Tribouilloy C, Massy ZA, Slama M.

Am J Physiol Heart Circ Physiol. 2012 Apr 1;302(7):H1524-32. doi: 10.1152/ajpheart.00955.2010. Epub 2012 Jan 27.

29.

Indoxyl sulphate inhibits osteoclast differentiation and function.

Mozar A, Louvet L, Godin C, Mentaverri R, Brazier M, Kamel S, Massy ZA.

Nephrol Dial Transplant. 2012 Jun;27(6):2176-81. doi: 10.1093/ndt/gfr647. Epub 2011 Dec 1.

PMID:
22140126
30.

Is vascular calcification associated with bone mineral density and osteoporotic fractures in ambulatory, elderly women?

Flipon E, Liabeuf S, Fardellone P, Mentaverri R, Ryckelynck T, Grados F, Kamel S, Massy ZA, Dargent-Molina P, Brazier M.

Osteoporos Int. 2012 May;23(5):1533-9. doi: 10.1007/s00198-011-1762-3. Epub 2011 Sep 8.

PMID:
21901478
31.

Potential anti-catabolic and anabolic properties of strontium ranelate.

Mentaverri R, Brazier M, Kamel S, Fardellone P.

Curr Mol Pharmacol. 2012 Jun;5(2):189-94. Review.

PMID:
21787286
32.

Tumor necrosis factor-related apoptosis-inducing ligand and vascular calcification.

Chasseraud M, Liabeuf S, Mozar A, Mentaverri R, Brazier M, Massy ZA, Kamel S.

Ther Apher Dial. 2011 Apr;15(2):140-6. doi: 10.1111/j.1744-9987.2010.00886.x. Epub 2011 Jan 25. Erratum in: Ther Apher Dial. 2011 Jun;15(3):338. Mentaveri, Romuald [corrected to Mentaverri, Romuald].

PMID:
21426505
33.

Strontium ranelate decreases receptor activator of nuclear factor-ΚB ligand-induced osteoclastic differentiation in vitro: involvement of the calcium-sensing receptor.

Caudrillier A, Hurtel-Lemaire AS, Wattel A, Cournarie F, Godin C, Petit L, Petit JP, Terwilliger E, Kamel S, Brown EM, Mentaverri R, Brazier M.

Mol Pharmacol. 2010 Oct;78(4):569-76. doi: 10.1124/mol.109.063347. Epub 2010 Jun 28.

PMID:
20584969
34.

Medicarpin inhibits osteoclastogenesis and has nonestrogenic bone conserving effect in ovariectomized mice.

Tyagi AM, Gautam AK, Kumar A, Srivastava K, Bhargavan B, Trivedi R, Saravanan S, Yadav DK, Singh N, Pollet C, Brazier M, Mentaverri R, Maurya R, Chattopadhyay N, Goel A, Singh D.

Mol Cell Endocrinol. 2010 Aug 30;325(1-2):101-9. doi: 10.1016/j.mce.2010.05.016. Epub 2010 Jun 4.

PMID:
20570709
35.

Implication of the calcium sensing receptor and the Phosphoinositide 3-kinase/Akt pathway in the extracellular calcium-mediated migration of RAW 264.7 osteoclast precursor cells.

Boudot C, Saidak Z, Boulanouar AK, Petit L, Gouilleux F, Massy Z, Brazier M, Mentaverri R, Kamel S.

Bone. 2010 May;46(5):1416-23. doi: 10.1016/j.bone.2010.01.383. Epub 2010 Feb 10.

PMID:
20149906
36.

Calcium-sensing receptor as a potential modulator of vascular calcification in chronic kidney disease.

Caudrillier A, Mentaverri R, Brazier M, Kamel S, Massy ZA.

J Nephrol. 2010 Jan-Feb;23(1):17-22. Review.

PMID:
20091482
37.

Agonists and allosteric modulators of the calcium-sensing receptor and their therapeutic applications.

Saidak Z, Brazier M, Kamel S, Mentaverri R.

Mol Pharmacol. 2009 Dec;76(6):1131-44. doi: 10.1124/mol.109.058784. Epub 2009 Sep 24. Review.

PMID:
19779033
38.

Oligogalacturonic acid inhibit bone resorption and collagen degradation through its interaction with type I collagen.

Lion JM, Mentaverri R, Rossard S, Jullian N, Courtois B, Courtois J, Brazier M, Mazière JC, Kamel S.

Biochem Pharmacol. 2009 Dec 15;78(12):1448-55. doi: 10.1016/j.bcp.2009.07.014. Epub 2009 Aug 6.

PMID:
19647720
39.

Extracellular signal-regulated kinases 1 and 2 and TRPC1 channels are required for calcium-sensing receptor-stimulated MCF-7 breast cancer cell proliferation.

El Hiani Y, Ahidouch A, Lehen'kyi V, Hague F, Gouilleux F, Mentaverri R, Kamel S, Lassoued K, Brûlé G, Ouadid-Ahidouch H.

Cell Physiol Biochem. 2009;23(4-6):335-46. doi: 10.1159/000218179. Epub 2009 May 6.

40.

Effects of calcimimetic on vascular calcification and atherosclerosis in uremic mice.

Joki N, Nikolov IG, Caudrillier A, Mentaverri R, Massy ZA, Drüeke TB.

Bone. 2009 Jul;45 Suppl 1:S30-4. doi: 10.1016/j.bone.2009.03.653. Epub 2009 Mar 19. Review.

PMID:
19303957
41.

Extracellular calcium promotes the migration of breast cancer cells through the activation of the calcium sensing receptor.

Saidak Z, Boudot C, Abdoune R, Petit L, Brazier M, Mentaverri R, Kamel S.

Exp Cell Res. 2009 Jul 15;315(12):2072-80. doi: 10.1016/j.yexcr.2009.03.003. Epub 2009 Mar 13.

PMID:
19285978
42.

The role of the calcium-sensing receptor in the development and progression of cancer.

Saidak Z, Mentaverri R, Brown EM.

Endocr Rev. 2009 Apr;30(2):178-95. doi: 10.1210/er.2008-0041. Epub 2009 Feb 23. Review.

PMID:
19237714
43.

Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer.

Weber G, Chamorro CI, Granath F, Liljegren A, Zreika S, Saidak Z, Sandstedt B, Rotstein S, Mentaverri R, Sánchez F, Pivarcsi A, Ståhle M.

Breast Cancer Res. 2009;11(1):R6. doi: 10.1186/bcr2221. Epub 2009 Jan 30.

44.

The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice.

Ivanovski O, Nikolov IG, Joki N, Caudrillier A, Phan O, Mentaverri R, Maizel J, Hamada Y, Nguyen-Khoa T, Fukagawa M, Kamel S, Lacour B, Drüeke TB, Massy ZA.

Atherosclerosis. 2009 Jul;205(1):55-62. doi: 10.1016/j.atherosclerosis.2008.10.043. Epub 2008 Nov 18.

PMID:
19118829
45.

The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways.

Hurtel-Lemaire AS, Mentaverri R, Caudrillier A, Cournarie F, Wattel A, Kamel S, Terwilliger EF, Brown EM, Brazier M.

J Biol Chem. 2009 Jan 2;284(1):575-84. doi: 10.1074/jbc.M801668200. Epub 2008 Oct 16.

46.

The pathophysiology of vascular calcification: are osteoclast-like cells the missing link?

Massy ZA, Mentaverri R, Mozar A, Brazier M, Kamel S.

Diabetes Metab. 2008 Feb;34 Suppl 1:S16-20. doi: 10.1016/S1262-3636(08)70098-3.

PMID:
18358422
47.

Multiple myeloma cells directly stimulate bone resorption in vitro by down-regulating mature osteoclast apoptosis.

Dib IE, Gressier M, Salle V, Mentaverri R, Brazier M, Kamel S.

Leuk Res. 2008 Aug;32(8):1279-87. doi: 10.1016/j.leukres.2007.12.018. Epub 2008 Feb 20. Erratum in: Leuk Res. 2008 Dec;32(12):1947. El Hajj Dib, Iman [corrected to Dib, Iman El Hajj]; Mélanie, Gressier [corrected to Gressier, Mélanie]; Valery, Salle [corrected to Salle, Valery]; Romuald, Mentaverri [corrected to Mentaverri, Romuald]; Michel, Brazier [corrected to Brazier, Michel].

PMID:
18282599
48.

High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells.

Mozar A, Haren N, Chasseraud M, Louvet L, Mazière C, Wattel A, Mentaverri R, Morlière P, Kamel S, Brazier M, Mazière JC, Massy ZA.

J Cell Physiol. 2008 Apr;215(1):47-54.

PMID:
17894387
49.

The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis.

Mentaverri R, Yano S, Chattopadhyay N, Petit L, Kifor O, Kamel S, Terwilliger EF, Brazier M, Brown EM.

FASEB J. 2006 Dec;20(14):2562-4. Epub 2006 Oct 31.

PMID:
17077282
50.

Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.

El Hajj Dib I, Gallet M, Mentaverri R, Sévenet N, Brazier M, Kamel S.

Eur J Pharmacol. 2006 Dec 3;551(1-3):27-33. Epub 2006 Sep 16.

PMID:
17049513

Supplemental Content

Loading ...
Support Center